Design of experiments and multivariate analysis approach to study dissolution stability of a modified-release drug product to support lean design strategies

References

• Merkle HP. Drug delivery's quest for polymers: where are the frontiers? Eur J Pharm Biopharm. 2015;97(Pt B):293–303.
   PubMedGoogle Scholar
• Tiwari SB, Rajabi-Siahboomi AR. Extended-Release oral drug delivery technologies: monolithic matrix systems. In: Jain KK, editor. Drug delivery systems. Totowa, NJ: Humana Press; 2008. p. 217–243.
   Google Scholar
• Ghori MU, Conway BR. Hydrophilic matrices for oral control drug delivery. Am J Pharm Sci. 2015;3(5):103–109.
   Google Scholar
• Körner A, Larsson A, Andersson Å, et al. Swelling and polymer erosion for poly(ethylene oxide) tablets of different molecular weights polydispersities. J Pharm Sci. 2010;99(3):1225–1238.
   PubMed Web of Science ®Google Scholar
• Ford JL, Rubinstein MH, Hogan JE. Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl-methylcellulose matrices. Int J Pharm. 1985;24(2):327–338.
   Google Scholar
• Ford JL, Rubinstein MH, Hogan JE. Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropylmethylcellulose. Int J Pharm. 1985;24(2–3):339–350.
   Web of Science ®Google Scholar
• Draksler P, Janković B, Abramović Z, et al. Assessment of critical material attributes of polyethylene oxide for formulation of prolonged-release tablets. Drug Dev Ind Pharm. 2019;45(12):1949–1958.
   PubMed Web of Science ®Google Scholar
• Draksler P, Mikac U, Laggner P, et al. Polyethylene oxide matrix tablet swelling evolution: the impact of molecular mass and tablet composition. Acta Pharm. 2021;71(2):215–243.
   PubMed Web of Science ®Google Scholar
• Cantin O, Siepmann F, Danède F, et al. PEO hot melt extrudates for controlled drug delivery: Importance of the molecular weight. J Drug Delivery Sci Technol. 2016;36:130–140.
   Web of Science ®Google Scholar
• Kim C-J. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets. Drug Dev Ind Pharm. 1998;24(7):645–651.
   PubMed Web of Science ®Google Scholar
• Maggi L, Bruni R, Conte U. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms. Int J Pharm. 2000;195(1–2):229–238.
   PubMedGoogle Scholar
• Sako K, Nakashima H, Sawada T, et al. Relationship between gelation rate of controlled-release acetaminophen tablets containing polyethylene oxide and colonic drug release in dogs. Pharm Res. 1996;13(4):594–598.
   PubMed Web of Science ®Google Scholar
• Kojima H, Yoshihara K, Sawada T, et al. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets. Eur J Pharm Biopharm. 2008;70(2):556–562.
   PubMed Web of Science ®Google Scholar
• Rhodes CT, Carstensen JT. Drug stability: principles and practices. 3rd ed., vol. 107. New York: Marcel Dekker; 2000.
   Google Scholar
• Halbert G. Drug stability, principles and practices, third edition, revised and expanded, edited by J.T. Carstensen and C.T. Rhodes, in drugs and the pharmaceutical sciences, vol. 107, Marcel Dekker, New York, 2000, ISBN 0-8247-0376-6. Int J Pharm. 2001;213(1–2):223–223.
   Google Scholar
• Waterman KC. The application of the accelerated stability assessment program (ASAP) to quality by design (QbD) for drug product stability. AAPS PharmSciTech. 2011;12(3):932–937.
   Google Scholar
• Waterman KC, Adami RC. Accelerated aging: prediction of chemical stability of pharmaceuticals. Int J Pharm. 2005;293(1–2):101–125.
   PubMed Web of Science ®Google Scholar
• Li J, Mooney DJ. Designing hydrogels for controlled drug delivery. Nat Rev Mater. 2016;1(12):16071.
   PubMed Web of Science ®Google Scholar
• Wen H, Jung H, Li X. Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. AAPS J. 2015;17(6):1327–1340.
   PubMed Web of Science ®Google Scholar
• Waterman KC, Adami RC, Alsante KM, et al. Stabilization of pharmaceuticals to oxidative degradation. Pharm Dev Technol. 2002;7(1):1–32.
   PubMed Web of Science ®Google Scholar
• Chen L, Yamane S, Sago T, et al. Experimental and modeling approaches for the formation of hydroperoxide during the auto-oxidation of polymers: thermal-oxidative degradation of polyethylene oxide. Chem Phys Lett. 2016;657:83–89.
   Web of Science ®Google Scholar
• Rane M, Parmar J, Tiwari S, et al. Application of polyethylene OXide in hydrophilic matrix tablets. Pharma Times. 2013;45:41–48.
   Google Scholar
• Puz MJ, Johnson BA, Murphy BJ. Use of the antioxidant BHT in asymmetric membrane tablet coatings to stabilize the core to the acid catalyzed peroxide oxidation of a thioether drug. Pharm Dev Technol. 2005;10(1):115–125.
   PubMed Web of Science ®Google Scholar
• Jordan N, Zakrajšek J, Bohanec S, et al. Applying the methodology of design of experiments to stability studies: a partial least squares approach for evaluation of drug stability. Drug Dev Ind Pharm. 2018;44(5):778–786.
   PubMed Web of Science ®Google Scholar
• Carlson R. Design of experiments, principles and applications, L. Eriksson, E. Johansson, N. Kettaneh-Wold, C. Wikström and S. Wold, Umetrics AB, Umeå Learnways AB, Stockholm. J Chemo. 2001;15(5):495–496.
   Google Scholar
• Ferreira AP, Tobyn M. Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era. Pharm Dev Technol. 2015;20(5):513–527.
   PubMed Web of Science ®Google Scholar
• Cook J, Cruañes MT, Gupta M, et al. Quality-by-design: are we there yet? AAPS PharmSciTech. 2014;15(1):140–148.
   PubMed Web of Science ®Google Scholar
• Mishra V, Thakur S, Patil A, et al. Quality by design (QbD) approaches in current pharmaceutical set-up. Expert Opin Drug Deliv. 2018;15(8):737–758.
   PubMed Web of Science ®Google Scholar
• Colgan ST, Timpano RJ, Roberts M, et al. Opportunities for lean stability strategies. J Pharm Innov. 2014;9(4):259–271.
   Web of Science ®Google Scholar
• Lin T-YD, Chen CW. Overview of stability study designs. J Biopharm Stat. 2003;13(3):337–354.
   PubMedGoogle Scholar